Cargando…
Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment
SIMPLE SUMMARY: Tricyclic antidepressants (TCAs) are old and known therapeutic agents whose good safety profile makes them good candidates for drug repurposing. As the relevance of nerves in cancer development and progression is being unveiled, attention now turns to the use of nerve-targeting drugs...
Autores principales: | Asensi-Cantó, Antonio, López-Abellán, María Dolores, Castillo-Guardiola, Verónica, Hurtado, Ana María, Martínez-Penella, Mónica, Luengo-Gil, Ginés, Conesa-Zamora, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265090/ https://www.ncbi.nlm.nih.gov/pubmed/35805019 http://dx.doi.org/10.3390/cancers14133248 |
Ejemplares similares
-
Analysis of the analgesic effects of tricyclic antidepressants on neuropathic pain, diabetic neuropathic pain, and fibromyalgia in rat models
por: Qin, Zhenlong, et al.
Publicado: (2020) -
Tricyclic antidepressants for preventing migraine in adults
por: Xu, Xiao-min, et al.
Publicado: (2017) -
Potential Utility of Induced Translocation of Engineered Bacteria as a Therapeutic Agent for Mounting a Personalized Neoantigen‐Based Tumor Immune Response
por: Luengo‐Gil, Ginés, et al.
Publicado: (2021) -
The tricyclic antidepressant clomipramine inhibits neuronal autophagic flux
por: Cavaliere, Federica, et al.
Publicado: (2019) -
Inhibition of N-type calcium ion channels by tricyclic antidepressants – experimental and theoretical justification for their use for neuropathic pain
por: Cardoso, Fernanda C., et al.
Publicado: (2021)